What is the treatment for a sinus infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Bacterial Sinusitis

For acute bacterial sinusitis, start with amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) for 10-14 days as first-line therapy, reserving amoxicillin-clavulanate and fluoroquinolones for treatment failures or specific high-risk situations. 1

Confirm the Diagnosis Before Prescribing Antibiotics

Most acute rhinosinusitis (98-99.5%) is viral and resolves spontaneously within 7-10 days without antibiotics. 1 Only prescribe antibiotics when bacterial infection is confirmed by one of three patterns: 1

  • Persistent symptoms ≥10 days without clinical improvement 1
  • Severe symptoms (fever ≥39°C with purulent nasal discharge and facial pain) for ≥3 consecutive days 1
  • "Double sickening" - worsening symptoms after initial improvement from a viral upper respiratory infection 1

Do not use purulent nasal discharge color alone to diagnose bacterial sinusitis, as mucus color reflects neutrophils, not bacteria. 1

First-Line Antibiotic Treatment

Standard First-Line Therapy

  • Amoxicillin 500 mg twice daily for mild, uncomplicated maxillary sinusitis 1
  • Amoxicillin 875 mg twice daily for moderate disease 1
  • Treatment duration: 10-14 days or until symptom-free for 7 days 1

When to Use Amoxicillin-Clavulanate as First-Line

Amoxicillin-clavulanate 875 mg/125 mg twice daily is preferred as first-line therapy in these situations: 1

  • Recent antibiotic exposure within past 4-6 weeks 1
  • Age <2 years or daycare attendance 1
  • Areas with high prevalence of β-lactamase-producing H. influenzae or M. catarrhalis 1
  • Moderate-to-severe disease 1

The clavulanate component provides coverage against β-lactamase-producing organisms that have become increasingly prevalent. 1

Treatment for Penicillin-Allergic Patients

Non-Severe Penicillin Allergy (Rash, Delayed Reactions)

Second- or third-generation cephalosporins are safe and effective, as the risk of cross-reactivity is negligible: 1

  • Cefuroxime-axetil (second-generation cephalosporin) 2, 1
  • Cefpodoxime-proxetil (third-generation, superior activity against H. influenzae) 2, 1
  • Cefdinir (third-generation, excellent coverage) 1

Severe Penicillin Allergy (Anaphylaxis, Type I Hypersensitivity)

Reserve respiratory fluoroquinolones for documented severe beta-lactam allergy: 1

  • Levofloxacin 500 mg once daily for 10-14 days 1, 3
  • Moxifloxacin 400 mg once daily for 10 days 1

Do not use azithromycin or other macrolides due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae. 1

Second-Line Treatment for Treatment Failure

If no improvement occurs after 3-5 days of initial antibiotic therapy, reassess the diagnosis and switch antibiotics: 1

If Initial Therapy Was Amoxicillin

Switch to high-dose amoxicillin-clavulanate: 1

  • Adults: 875 mg/125 mg twice daily (or 2000 mg/125 mg twice daily for severe cases) 1
  • Pediatrics: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1

If Initial Therapy Was Amoxicillin-Clavulanate

Switch to a respiratory fluoroquinolone: 1

  • Levofloxacin 500-750 mg once daily for 10-14 days (provides 90-92% predicted clinical efficacy against drug-resistant S. pneumoniae and β-lactamase-producing organisms) 1, 3
  • Moxifloxacin 400 mg once daily for 10 days 1

Alternative: Third-generation cephalosporins (cefpodoxime-proxetil or cefdinir) provide superior activity against H. influenzae but have limitations against drug-resistant S. pneumoniae. 1

Treatment Based on Sinusitis Location

Maxillary Sinusitis (Most Common)

  • First-line: Amoxicillin or amoxicillin-clavulanate as described above 2, 1
  • Symptoms: Unilateral or bilateral infraorbital pain worsening when bending forward, pulsatile, peaking in evening/night 2

Frontal, Ethmoidal, or Sphenoidal Sinusitis

These locations carry high risk of complications and require more aggressive therapy: 2, 1

  • Fluoroquinolones (levofloxacin or moxifloxacin) are recommended as first-line therapy due to potential for serious complications 2, 1
  • Hospitalization, bacteriological testing, and parenteral antibiotics are indicated if complications are suspected (meningeal syndrome, exophthalmos, palpebral edema, ocular mobility disorders, severe pain preventing sleep) 2

Adjunctive Therapies That Actually Work

Intranasal Corticosteroids (Strongly Recommended)

Intranasal corticosteroids significantly reduce symptoms and should be added to antibiotic therapy: 1, 4

  • Mometasone, fluticasone, or budesonide twice daily 1
  • Reduces mucosal inflammation, improves symptom resolution, and may decrease antibiotic use 1, 4
  • Patients receiving intranasal corticosteroids with antibiotics had significantly greater reduction in headache, facial pain, and congestion compared to antibiotics alone 4

Oral Corticosteroids (Limited Use)

Short-term oral corticosteroids may be reasonable for: 1

  • Patients who fail to respond to initial treatment 1
  • Marked mucosal edema 1
  • Acute hyperalgic sinusitis (severe pain) 1
  • Typical regimen: 5 days 1

Never give systemic corticosteroids without antibiotics when bacterial sinusitis is suspected, as this may suppress immune response and allow bacterial proliferation. 1

Supportive Measures

  • Analgesics (acetaminophen, NSAIDs) for pain relief 1
  • Saline nasal irrigation for symptomatic relief and mechanical removal of mucus 1, 5
  • Adequate hydration, warm facial packs, sleeping with head elevated 1
  • Decongestants (systemic or topical) may provide symptomatic relief but have limited evidence for efficacy 1

Pediatric Dosing Considerations

  • Standard-dose amoxicillin: 45 mg/kg/day in 2 divided doses for uncomplicated disease 1
  • High-dose amoxicillin: 80-90 mg/kg/day in 2 divided doses for high-risk children (age <2 years, daycare attendance, recent antibiotic use, areas with high prevalence of resistant S. pneumoniae) 1
  • High-dose amoxicillin-clavulanate: 90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 1
  • Ceftriaxone 50 mg/kg IM or IV once daily for children unable to tolerate oral medication 1

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for symptoms lasting <7 days unless severe symptoms are present, as most cases are viral 1, 6
  • Do not use azithromycin due to resistance rates of 20-25% 1
  • Do not use trimethoprim-sulfamethoxazole due to high resistance rates 1
  • Do not use clindamycin as monotherapy - it lacks activity against H. influenzae and M. catarrhalis 1
  • Reserve fluoroquinolones for treatment failures or severe beta-lactam allergy to prevent resistance development 1
  • Reassess patients at 3-5 days - if no improvement, switch antibiotics or re-evaluate diagnosis 1
  • Complete the full antibiotic course even after symptoms improve to prevent relapse 1

When to Refer to a Specialist

Refer to otolaryngology when: 1, 5

  • Symptoms refractory to two courses of appropriate antibiotics 1
  • Recurrent sinusitis (≥3 episodes per year) 1
  • Suspected complications (orbital cellulitis, meningitis, severe frontal/ethmoidal/sphenoidal sinusitis) 2, 1
  • Need for sinus aspiration/culture in immunocompromised patients 1
  • Evaluation for underlying allergic rhinitis, immunodeficiency, or anatomical abnormalities 1, 5

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chronic Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.